Effects of a Tailored Text Messaging Intervention Among Diverse Adults With Type 2 Diabetes: Evidence From the 15-Month REACH Randomized Controlled Trial

Author:

Nelson Lyndsay A.12,Greevy Robert A.3,Spieker Andrew3,Wallston Kenneth A.4,Elasy Tom A.15,Kripalani Sunil1,Gentry Chad6,Bergner Erin M.12,LeStourgeon Lauren M.12,Williamson Sarah E.12,Mayberry Lindsay S.1257ORCID

Affiliation:

1. Department of Medicine, Vanderbilt University Medical Center, Nashville, TN

2. Center for Health Behavior and Health Education, Vanderbilt University Medical Center, Nashville, TN

3. Department of Biostatistics, Vanderbilt University, Nashville, TN

4. Institute for Medicine and Public Health, Vanderbilt University Medical Center, Nashville, TN

5. Center for Diabetes Translation Research, Vanderbilt University Medical Center, Nashville, TN

6. Department of Pharmacy, College of Pharmacy and Health Sciences, Lipscomb University, Nashville, TN

7. Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN

Abstract

OBJECTIVE Text messaging interventions have high potential for scalability and for reductions in health disparities. However, more rigorous, long-term trials are needed. We examined the long-term efficacy and mechanisms of a tailored text messaging intervention. RESEARCH DESIGN AND METHODS Adults with type 2 diabetes participated in a parallel-groups, 15-month randomized controlled trial and were assigned to receive Rapid Education/Encouragement and Communications for Health (REACH) for 12 months or control. REACH included interactive texts and tailored texts addressing medication adherence and nontailored texts supporting other self-care behaviors. Outcomes included hemoglobin A1c (HbA1c), diabetes medication adherence, self-care, and self-efficacy. RESULTS Participants (N = 506) were approximately half racial/ethnic minorities, and half were underinsured, had annual household incomes <$35,000, and had a high school education or less; 11% were homeless. Average baseline HbA1c was 8.6% ± 1.8%; 70.0 ± 19.7 mmol/mol) with n = 219 having HbA1c ≥8.5% (69 mmol/mol). Half were prescribed insulin. Retention was over 90%. Median response rate to interactive texts was 91% (interquartile range 75%, 97%). The treatment effect on HbA1c at 6 months (−0.31%; 95% CI −0.61%, −0.02%) was greater among those with baseline HbA1c ≥8.5% (−0.74%; 95% CI −1.26%, −0.23%), and there was no evidence of effect modification by race/ethnicity or socioeconomic disadvantage. REACH improved medication adherence and diet through 12 months and self-efficacy through 6 months. Treatment effects were not significant for any outcome at 15 months. REACH reduced barriers to adherence, but barrier reduction did not mediate outcome improvements. CONCLUSIONS REACH engaged at-risk patients in diabetes self-management and improved short-term HbA1c. More than texts alone may be needed to sustain the effects.

Funder

National Institute of Diabetes and Digestive and Kidney Diseases

National Heart, Lung, and Blood Institute

Publisher

American Diabetes Association

Subject

Advanced and Specialized Nursing,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference40 articles.

1. The ‘cost’ of medication nonadherence: consequences we cannot afford to accept;Chisholm-Burns;J Am Pharm Assoc,2003

2. Medication adherence with diabetes medication: a systematic review of the literature;Capoccia;Diabetes Educ,2016

3. Poor medication adherence in type 2 diabetes: recognizing the scope of the problem and its key contributors;Polonsky;Patient Prefer Adherence,2016

4. Self-care disparities among adults with type 2 diabetes in the USA;Mayberry;Curr Diab Rep,2016

5. Trends in health equity in the United States by race/ethnicity, sex, and income, 1993-2017;Zimmerman;JAMA Netw Open,2019

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3